Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

BE1218 is an inverse agonist of liver X receptor α (LXRα) and LXRβ (IC50s = 9 and 7 nM, respectively).1 It reduces the expression of the LXR target FASN, the gene encoding fatty acid synthase, in HepG2 hepatocytes and DU145 prostate cancer cells at 1 µM.
WARNING This product is not for human or veterinary use.
1. Synthesis and structure activity relationship of the first class of LXR inverse agonists. Bioorg. Chem. 119:105540, (2022).